Cholangiocarcinoma: Molecular Pathways and Therapeutic Opportunities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cholangiocarcinoma: Molecular Pathways and Therapeutic Opportunities

Published:2014-11-04 Issue:04 Volume:34 Page:456-464
ISSN:0272-8087
Container-title:Seminars in Liver Disease
language:en
Short-container-title:Semin Liver Dis

Author:

Rizvi Sumera¹,Borad Mitesh²,Patel Tushar³,Gores Gregory¹

Affiliation:

1. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota

2. Division of Hematology and Oncology, Mayo Clinic, Scottsdale, Arizona

3. Departments of Internal Medicine, Transplantation and Cancer Biology, Mayo Clinic, Jacksonville, Florida

Publisher

Georg Thieme Verlag KG

Subject

Hepatology

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0034-1394144.pdf

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can NPC1L1 inhibitors reduce the risk of biliary tract cancer? Evidence from a mendelian randomization study;Digestive and Liver Disease;2024-09

2. Predicting Survival Rates: The Power of Prognostic Nomograms in Distal Cholangiocarcinoma;2024-06-04

3. The Diagnostic and Prognostic Potentials of Non-Coding RNA in Cholangiocarcinoma;International Journal of Molecular Sciences;2024-05-30

4. Microcystin-leucine arginine induces the proliferation of cholangiocytes and cholangiocarcinoma cells through the activation of the Wnt/β-catenin signaling pathway;Heliyon;2024-05

5. Current and Future Therapeutic Targets for Directed Molecular Therapies in Cholangiocarcinoma;Cancers;2024-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP